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A rare case of primary adenosquamous carcinoma 
arising from ovary
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Primary adenosquamous carcinoma of ovary is extremely rare malignancy. We report a case of primary adenosquamous carci-
noma of the ovary which has not been reported in Korea before. The case of a 32 year old woman, evaluated for palpable ab-
dominal mass is presented. Ultrasonography, abdomino-pelvic MRI, PET-CT were suggestive of a malignant neoplastic 
process. Surgical debulking operation including total abdominal hysterectomy, bilateral salpingo-oophorectomy, bilateral pel-
vic lymph node dissection, para-aortic lymph node biopsy, total omentectomy, incidental appendectomy and low anterior re-
section of rectum were performed. Histopathology demonstrated primary adenosquamous carcinoma arising from the left ova-
ry to the myometrium, serosa, rectal wall mass and omentum. The staging for ovarian tumor was consistent with FIGO stage 
IV. We present a case of this rare malignancy
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Introduction
Adenosquamous cell carcinoma of the ovary is a rare 
clinical entity, accounting for less than 1% of all malignant 
tumors of the ovary. The occurrence is associated with ma-
lignant tansformation of an preexisting ovarian dermoid 
cyst or endometriosis.1-4 It is attributable to the underlying 
pathophysiological mechanism, and this phenomenon is 
considered rare, as only 1 to 2% of dermoid cyst present this 
change.2,3 A smaller group of squamous carcinomas are 
found in association with ovarian endometriosis.1,4 The pri-
mary adenosquamous carcinoma of ovary is extremely rare 
malignancy.5-8 The purpose of the report is to present a pa-
tient with primary adenosquamous carcinoma of ovary.
Case Report
A 32-year-old, para 1, woman was referred to the general 
surgery clinic for a palpable mass on left lower abdomen. 
She had no history of weight loss, change in appetite, bowel 
habit or menstrual flow. A recent pap smear was negative 
for intraepithelial lesion or malignancy. On physical exami-
nation, she was not anemic with no jaundice, lymphadeno-
pathy. Abdominal examination revealed a firm, mildly ten-
der, mobile mass occupying most of the lower abdomen. 
There was no clinical evidence of ascites. Tumor marker 
profile was as follows: CA-125, 97.5 ng/mL (normal, 0 to 35 
U/mL); CA 19-9, 34.8 U/mL (normal, 0 to 40  U/mL); CEA, 
1.83 ng/mL (normal, 0 to 5.0 U/mL); alpha fetoprotein, 1.38 
ng/mL (normal, 0 to 75 ng/mL). Abdomino- pelvic mag-
netic resonance imaging (MRI) and positron emission to-
mography-computed tomography (PET-CT) revealed a het-
erogenous mass (11×9×8.5 cm) occupying the lower abdo-
men arising from left adenexa (Figs. 1, 2A). There was a fo-
cal nodular increased uptake in the right perihepatic space 
and focal increased uptake in the right ischium, suggestive 
of skeletal metastasis. Linearly increased uptake in the spi-
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Fig. 1. Magnetic resonance imaging scan of the pelvis show-
ing the tumour mass.
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Fig. 2. (A) Positron emission tomography-computed tomography (PET-CT) of the pelvis showing the tumour mass. (B) PET-CT 
of the skelectal metastasis. (C) PET-CT of the skelectal metastasis. (D) PET-CT of the liver metastasis.
nal canal at the level of the T12-L1 was noted (Fig. 2B~2D).
Operative findings were that about 11×9 cm sized left 
ovarian mass with normal ovarian parenchyma, and left 
ovarian tumor with rectal invasion. Left salpingo-oopho-
rectomy was performed for frozen biopsy which revealed 
high-grade malignancy. She underwent debulking operation 
including total abdominal hysterectomy, right salpingo- 
oophorectomy, bilateral pelvic lymph node dissection, 
para-aortic lymph node biopsy, total omentectomy, inciden-
tal appendectomy and low anterior resection of rectum. 
There was no residual tumor. The pathologic finding con-
firmed malignant mixed epithelial tumor (adenosquamous 
carcinoma) from the left ovary with extention to the myome-
trium and serosa, rectum and omentum with evidence of 
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Fig. 4. (A) Positron emission tomography-computed tomography (PET-CT) of the skelectal metastasis after chemotherapy. (B) 
PET-CT of the liver metastasis after chemotherapy.
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Fig. 3. (A) Histologic appearance of the resected ovarian tumor showing malignant mixed epithelial tumor (adenosquamous carci-
noma) (H&E stain, ×40). (B) Histologic appearance of the resected ovarian tumor showing adenocarcinoma (H&E stain, ×100).
(C) Histologic appearance of the resected ovarian tumor showing squamous cell carcinoma. Hyperkeratinization is noted (H&E 
stain, ×100). 
keratinization. There was no concomitant teratoma or fea-
tures suggestive of endometriosis. All the resection margins 
and the 27 resected lymph nodes were free form tumor. 
Microscopic examination showed a cyst wall lined by squ-
amous cell carcinoma characterized by keratinized squ-
amous cells with enlarged, hyperchromatic nuclei, increased 
nuclear/cytoplasmic ratios, loss of polarity of the nuclei, and 
frequent mitoses extending to the surface (Fig. 3A, 3C). In 
some areas the adenocarcinomas were markedly pleomor-
phic with well-formed glands (Fig. 3B, 3C). Histologic ap-
pearance of the resected ovarian tumor showed malignant 
mixed epithelial tumor (adenosquamous carcinoma). There 
was no evidence of the origin of teratoma or endometriosis. 
(Fig. 3) The surgical staging was compatible with Interna-
tional Federation of Gynecology and Obstetrics (FIGO) 
stage IV of ovary. Her postoperative recovery was unre-
markerable.
The patient was treated with Paclitaxel 175 mg/m2 over 
24 hours and Carboplatin area under curve 5 every 3 weeks. 
The patient’s CA-125 was 42.4 IU/mL at the time of her 
second chemotherapy course. Despite adjuvant chemo-
therapy over the course of the next four months, her disease 
progressed. On PET-CT whole body scan, there was tumor 
progression with metastases to the liver, right ischium, and 
pelvis (Fig. 4). The patient’s CA-125 was 361.4 IU/ mL. We 
changed the chemotherapy regimen. The patient was treated 
with Belotecan 0.5 mg/m2 #1~5 days and Cisplatin 60 
mg/m2 every 3 weeks. After chemotherapy, the patient re-
fused further evaluation and treatment. She died 3 months 
later.
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Discussion
Ovarian cancer is the second common female genital tract 
malignancy. The common ovarian tumors originate from the 
surface epithelium of the ovary. The cases of primary ad-
enosquamous cell carcinomas originate from ovaries are ex-
tremely rare. In rare case, it is reported that the dermoids 
cyst or endometriotc cyst provide a background of malimg-
nant transformation within components of the teratoma or 
endometriotic cyst.1-4 In the reported cases of primary ovar-
ian adenosquamous carcinoma, the majority were related 
with cervical dysplasia. Such a relation however was not ap-
parent in our case as demonstrated by a negative pre-oper-
ative pap smear and confirmed by post operative surgical 
pathology. 
Because of the rarity of the condition, the optimal ma-
nagement to primary ovarian adenosquamous cell carcino-
mas is unclear. Reported cases suggest that the surgical 
management is similar to that of adenocarcinomas of the 
ovary, including total abdominal hysterectomy, bilateral sal-
pingo-oophorectomy, bilateral pelvic lymph node dissec-
tion, para-aortic lymph node biopsy, with additional steps as 
needed to ensure surgical debulking of all grossly visible 
mass. Optimal surgical cytoreduction and the surgical stage 
at presentation have been correlated with a significantly im-
proved survival for adenosquamous carcinomas originating 
from dermoid or endometriotic cysts. The role of adjuvant 
therapy in the postoperative treatment of ovarian adenosqu-
amous cell carcinomas is unclear. Because squamous cell 
carcinoma is radiation sensitive, radiotherapy has been used 
with the rationale of adenosquamous cell carcinoma being a 
radiosensitive tumor. However, there is no evidence that ra-
diation therapy improves survival rate. In previous reports 
with ovarian squamous cell carcinoma, whole-pelvis radia-
tion and concurrent weekly platinum- based chemotherapy 
following cytoreduction operation has shown benefit.9,10 
However, it is unclear whether patients with primary ad-
enosquamous carcinoma of the ovary would benefit as much 
from similar adjuvant therapy.
In conclusion, primary adenosquamous carcinoma ari-
sing from the ovary is extremely rare. Because of the limited 
number of cases reported with adenosquamous cell carcino-
ma, not only the progress but also management of adenosqu
amous cell carcinoma has not been determined. The primary 
management at present is surgical debulking and com-
bination chemotherapy with newer drugs. However, in the 
absence of quality data, except for the very early stages of 
presentation, a role for adjuvant therapy is at present 
unclear. 
Our patient showed a rapidly progressive disease in the 
four months after the operation. The chemotherapy regi-
mens or their dosages may be ineffective for this malignant 
cell type of the ovary and more clinical investigations are 
needed.
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